Matthew Kraman
0000-0002-5040-0067
Publication & Citation Trends
Most Cited Works
Publications
47 total
FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
Cited by 106
OpenAlex
Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics
Cited by 30
OpenAlex
Abstract 2719: Dual blockade of PD-L1 and LAG-3 with FS118, a unique bispecific antibody, induces CD8+ T-cell activation and modulates the tumor microenvironment to promote antitumor immune responses
Cited by 14
OpenAlex
The protein phosphatase 2A B56γ regulatory subunit is required for heart development PDF
Cited by 35
OpenAlex
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
Cited by 1,969
OpenAlex
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia PDF
Cited by 403
OpenAlex
Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1 PDF
Cited by 167
OpenAlex
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Cited by 1,117
OpenAlex
Research Topics
Cancer, Hypoxia, and Metabolism
(22)
Eicosanoids and Hypertension Pharmacology
(17)
Cancer Immunotherapy and Biomarkers
(13)
Immune cells in cancer
(11)
Heme Oxygenase-1 and Carbon Monoxide
(11)
Frequent Co-Authors
Affiliations
Center for Biologics Evaluation and Research
United States Food and Drug Administration
MRC Laboratory of Molecular Biology
Wellcome/MRC Cambridge Stem Cell Institute
University of Cambridge